ARENA, UMBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.888
EU - Europa 1.353
AS - Asia 1.128
SA - Sud America 183
AF - Africa 41
OC - Oceania 13
Totale 4.606
Nazione #
US - Stati Uniti d'America 1.859
RU - Federazione Russa 463
SG - Singapore 303
CN - Cina 300
PL - Polonia 276
IT - Italia 194
BR - Brasile 151
HK - Hong Kong 149
VN - Vietnam 128
IE - Irlanda 95
KR - Corea 89
SE - Svezia 79
FI - Finlandia 66
DE - Germania 57
FR - Francia 48
IN - India 41
JO - Giordania 39
GB - Regno Unito 30
JP - Giappone 20
CA - Canada 19
NL - Olanda 19
BD - Bangladesh 16
ID - Indonesia 14
AU - Australia 12
EG - Egitto 10
AR - Argentina 9
ZA - Sudafrica 9
ES - Italia 7
PE - Perù 7
MX - Messico 6
DZ - Algeria 5
NG - Nigeria 5
DK - Danimarca 4
MA - Marocco 4
PH - Filippine 4
UY - Uruguay 4
CL - Cile 3
IQ - Iraq 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
BJ - Benin 2
CI - Costa d'Avorio 2
EC - Ecuador 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
TG - Togo 2
TR - Turchia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
HR - Croazia 1
HU - Ungheria 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 4.606
Città #
Santa Clara 442
Ashburn 283
Warsaw 272
Singapore 211
Fairfield 151
Hong Kong 128
Dublin 94
Seoul 87
Chandler 74
Hefei 74
San Jose 74
Woodbridge 61
Beijing 53
Houston 50
Helsinki 48
Ho Chi Minh City 48
Seattle 46
Cambridge 45
Florence 40
Wilmington 39
Los Angeles 37
São Paulo 33
Buffalo 28
Hanoi 28
Altamura 26
Council Bluffs 26
Lawrence 26
Munich 25
New York 24
Lauterbourg 23
Mumbai 18
Princeton 18
Ann Arbor 17
Moscow 15
Dallas 14
Rome 14
Boston 13
Shanghai 12
The Dalles 12
Jakarta 10
London 10
Melbourne 10
Paris 10
Sapporo 10
Clifton 9
Frankfurt am Main 9
Kent 9
Tokyo 9
City of London 8
Naples 8
Turku 8
Bremen 7
Cairo 7
Lappeenranta 7
Milan 7
Riverside 6
Shenzhen 6
Toronto 6
Atlanta 5
Bologna 5
Medford 5
Rio de Janeiro 5
Abuja 4
Almere Stad 4
Bengaluru 4
Bexley 4
Brooklyn 4
Dong Ket 4
Falls Church 4
Grandate 4
Guangzhou 4
Lima 4
Montreal 4
Phoenix 4
Porto Alegre 4
Redondo Beach 4
San Diego 4
San Francisco 4
Amman 3
Can Tho 3
Chongqing 3
Columbus 3
Da Nang 3
Haiphong 3
Hillsboro 3
Johannesburg 3
Kalundborg 3
Manaus 3
Miami 3
Montevideo 3
Orem 3
Ottawa 3
Perugia 3
Salt Lake City 3
Tashkent 3
Villaricca 3
Volta Redonda 3
Wroclaw 3
Abidjan 2
Amsterdam 2
Totale 3.033
Nome #
Acute on chronic liver failure: From pathophysiology to clinical management. 329
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 302
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 262
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 230
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 220
A large rheumatoid nodule mimicking hepatic malignancy 215
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 209
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 202
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 197
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 196
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 182
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 181
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 158
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 158
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 155
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 153
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms 149
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 149
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 141
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 129
Time-varying mHAP III is the most accurate predictor of survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 126
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution? 125
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life 124
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter 112
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial 111
Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 93
Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPS 46
Totale 4.654
Categoria #
all - tutte 12.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022125 1 15 11 4 1 4 8 6 11 9 22 33
2022/2023417 28 72 29 18 32 70 50 36 59 2 15 6
2023/2024179 6 18 26 7 14 33 7 26 5 13 11 13
2024/20251.410 60 126 78 208 335 211 26 82 86 35 54 109
2025/20261.745 223 280 195 152 175 78 219 100 115 128 79 1
Totale 4.654